Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume 47, Issue 6, Pages 1180-1187
Publisher
Springer Science and Business Media LLC
Online
2022-02-25
DOI
10.1038/s41386-022-01297-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches
- (2021) Albert Garcia-Romeu et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Trial of Psilocybin versus Escitalopram for Depression
- (2021) Robin Carhart-Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety pharmacology of acute LSD administration in healthy subjects
- (2021) Friederike Holze et al. PSYCHOPHARMACOLOGY
- Role of the 5-HT2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin
- (2021) Friederike Holze et al. Frontiers in Pharmacology
- Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects
- (2021) Anna M. Becker et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
- (2020) Friederike Holze et al. NEUROPSYCHOPHARMACOLOGY
- Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma
- (2020) Karolina E. Kolaczynska et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
- (2019) Martin K. Madsen et al. NEUROPSYCHOPHARMACOLOGY
- Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects
- (2019) Friederike Holze et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
- (2019) Friederike Holze et al. NEUROPSYCHOPHARMACOLOGY
- High dose psilocybin is associated with positive subjective effects in healthy volunteers
- (2018) Christopher R Nicholas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psychedelics Promote Structural and Functional Neural Plasticity
- (2018) Calvin Ly et al. Cell Reports
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
- (2018) Leor Roseman et al. Frontiers in Pharmacology
- Modern Clinical Research on LSD
- (2017) Matthias E Liechti NEUROPSYCHOPHARMACOLOGY
- Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences
- (2017) Theresa M. Carbonaro et al. PSYCHOPHARMACOLOGY
- Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
- (2016) Anna Rickli et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Alterations of consciousness and mystical-type experiences after acute LSD in humans
- (2016) Matthias E. Liechti et al. PSYCHOPHARMACOLOGY
- Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
- (2015) Yasmin Schmid et al. BIOLOGICAL PSYCHIATRY
- Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
- (2015) Frederick S Barrett et al. JOURNAL OF PSYCHOPHARMACOLOGY
- LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
- (2014) Peter Gasser et al. JOURNAL OF PSYCHOPHARMACOLOGY
- No Evidence that MDMA-Induced Enhancement of Emotional Empathy Is Related to Peripheral Oxytocin Levels or 5-HT1a Receptor Activation
- (2014) Kim P. C. Kuypers et al. PLoS One
- Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression
- (2013) C. N. Haile et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
- (2011) Roland R. Griffiths et al. PSYCHOPHARMACOLOGY
- Effects of a -blocker on the cardiovascular response to MDMA (Ecstasy)
- (2010) C. M. Hysek et al. EMERGENCY MEDICINE JOURNAL
- Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies
- (2010) Erich Studerus et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
- (2010) Erich Studerus et al. PLoS One
- Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI
- (2008) Danuta Marona-Lewicka et al. PSYCHOPHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started